当前位置:首页 - 行情中心 - 名臣健康(002919) - 财务分析 - 现金流量表

名臣健康

(002919)

  

流通市值:67.26亿  总市值:67.75亿
流通股本:2.65亿   总股本:2.67亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金377,537,792.061,340,279,759.59923,775,199.56600,230,285.39
  收到的税费返还-137,871.11137,871.11137,871.11
  收到其他与经营活动有关的现金7,310,502.098,113,295.814,274,582.882,065,954.87
  经营活动现金流入小计384,848,294.151,348,530,926.51928,187,653.55602,434,111.37
  购买商品、接受劳务支付的现金244,498,153.21892,041,242.82622,079,280.28422,382,370.78
  支付给职工以及为职工支付的现金63,286,205.4194,204,754.9144,728,270.05103,311,205.97
  支付的各项税费8,345,103.9447,797,639.0135,798,928.6121,997,177.97
  支付其他与经营活动有关的现金54,718,890.58126,833,561.6785,678,370.0855,571,109.11
  经营活动现金流出小计370,848,353.131,260,877,198.4888,284,849.02603,261,863.83
  经营活动产生的现金流量净额13,999,941.0287,653,728.1139,902,804.53-827,752.46
二、投资活动产生的现金流量:
  收回投资收到的现金87,181,871.5374,507,000238,150,000181,610,000
  取得投资收益收到的现金47,560.691,244,025.57500,017.72490,820.7
  处置固定资产、无形资产和其他长期资产收回的现金净额-10,789.9116,187.2310,789.91
  投资活动现金流入小计87,229,432.19375,761,815.48238,666,204.95182,111,610.61
  购建固定资产、无形资产和其他长期资产支付的现金11,938,389.1586,514,291.0561,766,517.6739,756,229.72
  投资支付的现金142,540,000328,410,000234,170,000191,010,000
  投资活动现金流出小计154,478,389.15414,924,291.05295,936,517.67230,766,229.72
  投资活动产生的现金流量净额-67,248,956.96-39,162,475.57-57,270,312.72-48,654,619.11
三、筹资活动产生的现金流量:
  取得借款收到的现金-80,000,00030,000,00030,000,000
  收到其他与筹资活动有关的现金--14,544.1614,544.16
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-80,000,00030,014,544.1630,014,544.16
  分配股利、利润或偿付利息支付的现金602,50013,783,247.7413,534,053.313,327,053.3
  支付其他与筹资活动有关的现金2,633,052.9946,130,020.1942,972,192.0627,205,982.37
  筹资活动现金流出小计3,235,552.9959,913,267.9356,506,245.3640,533,035.67
  筹资活动产生的现金流量净额-3,235,552.9920,086,732.07-26,491,701.2-10,518,491.51
四、汇率变动对现金及现金等价物的影响-523,753.9-266,222.822,464.56100,273.77
五、现金及现金等价物净增加额-57,008,322.8368,311,761.79-43,856,744.83-59,900,589.31
  加:期初现金及现金等价物余额237,267,679.14168,955,917.35168,955,917.35168,955,917.35
  期末现金及现金等价物余额180,259,356.31237,267,679.14125,099,172.52109,055,328.04
补充资料:
  净利润-27,801,249.12-41,057,529.38
  资产减值准备-68,284,168.45-2,076,856.43
  固定资产和投资性房地产折旧-7,891,171.07-4,016,978.65
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-7,891,171.07-4,016,978.65
  无形资产摊销-2,742,148.82-819,176.89
  长期待摊费用摊销-13,751,387.03-5,903,654.87
  处置固定资产、无形资产和其他长期资产的损失-510,953.34--233,240.96
  固定资产报废损失-33,101.27--
  公允价值变动损失--102,684,755--309,669.4
  财务费用-1,804,851.98-307,053.4
  投资损失--342,486.32--147,972.13
  递延所得税-20,891,690.54--11,273,641.91
  其中:递延所得税资产减少--1,961,948.67--11,308,319.24
    递延所得税负债增加-22,853,639.21-34,677.33
  存货的减少-1,367,498.19-3,637,673.86
  经营性应收项目的减少--40,230,383.79--11,835,010.43
  经营性应付项目的增加-72,696,380.7--41,101,041.39
  其他---4,655.42
  现金的期末余额-237,267,679.14-109,055,328.04
  减:现金的期初余额-168,955,917.35-168,955,917.35
  现金及现金等价物的净增加额-68,311,761.79--59,900,589.31
公告日期2026-04-282026-04-282025-10-292025-08-29
审计意见(境内)标准无保留意见
TOP↑